The Science Behind MemorAmp
Our technology is built on years of research into Alzheimer’s and dementia biomarkers. By combining graphene biosensors with advanced biochemistry, MemorAmp detects Alzheimer's linked biomarkers earlier than traditional methods.
What We Measure
Alzheimer’s and related dementias leave early molecular “footprints” in the body. These biomarkers are proteins that can be detected long before symptoms appear.
Grid Layout (4 Cards):
Amyloid-beta (Aβ42): linked to plaque formation.
Tau: indicates brain cell damage.
Alpha-synuclein: tied to Parkinson’s and dementia.
TDP-43: associated with frontotemporal dementia.
Detecting Disease Before It Shows
Traditional Alzheimer’s diagnosis relies on memory tests or brain scans, often after the disease has progressed. Biomarker detection allows us to intervene years earlier, giving patients and families the gift of time.
Ultra-Sensitive Graphene Biosensors
Graphene, one of the strongest and most conductive materials on Earth, allows us to detect biomarkers at ultra-low concentrations. Paired with DNA aptamers (molecules that “lock” onto specific proteins), our biosensors offer unmatched accuracy and speed.
Memoramp: From Concept to Creation
Memoramp began as a scientific exploration into how humans retain and connect knowledge. Born in the Science Lab, it evolved into a platform that transforms research into collective memory.
Publications
MemorAmp Papers and Patents (2016–2025)
Single-Molecule DNA Detection with GFET
Between 2016 and 2022, MemorAmp advanced graphene field-effect transistor (GFET) sensors for single-molecule DNA and RNA detection. Using aptamer-based probes, this portable system enabled label-free, real-time analysis — a breakthrough for personalized diagnostics and pandemic response.
Includes PNAS (2016) and COVID-19 detection patents (2017).
Biomarker Detection for Alzheimer’s Disease
Using aptamer-modified GFETs, MemorAmp detected Alzheimer’s biomarkers from human brain tissue. Published in PNAS (2023) with a 2024 patent for dementia diagnostics, this innovation paved the way for noninvasive early detection of neurodegenerative diseases.